In a Tlr3, Tlr7 and Tlr9 knockout mouse model, transplantable tumour cells were rejected after 10 days and this was associated with differences in inflammation and an effective CD8+ T‐cell response, suggesting that TLR signalling in non‐malignant cells may regulate antitumour immune responses [43]. This evidence concerns the gene CD8A and neoplasm.